je.st
news
Tag: annual
Brightoil To See 500M CBM Increase in Annual Gas Production With Xinjiang Gas Production Enhancement Plans
2015-06-01 02:24:29| chemicalonline Home Page
Brightoil Petroleum (Holdings) Limited (“Brightoil Petroleum” or the “Group”; stock code: 933.HK) is pleased to announce that its two wholly owned subsidiaries will conclude agreements with the Second Exploration Branch of PetroChina and the Sixth Exploration Branch of China Petroleum & Chemical Corporation on the new drilling and ground project construction for the Tuzi and Dina 1 Gas Fields in Xinjiang
Tags: increase
production
plans
annual
16,000 TELUS Volunteers Celebrate 10th Annual TELUS Days of Giving
2015-05-30 23:58:03| Telecom - Topix.net
More than 16,000 TELUS team members, retirees, friends and family members across Canada are supporting a 10 year TELUS tradition by giving back with their hearts and hands and doing #actsofgood at more than 1,000 charitable and community activities during TELUS Days of Giving from May 16 to June 14. Most activities will take place today, with volunteers coming together to serve breakfast to the homeless, build tactile books for blind children and escort disabled adults to a community waterfront event. Held annually, TELUS Days of Giving was launched in 2006 as the TELUS National Day of Service.
First Study Evaluating DNA Mismatch Repair as Genetic Guide for Immunotherapy Treatment with Mercks KEYTRUDA (pembrolizumab) Presented at 2015 ASCO Annual Meeting and Published in the New England Journal of Medicine
2015-05-29 20:05:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Early Findings Show DNA Mismatch Repair-Deficient Colorectal and Other Tumors Highly Responsive to Checkpoint Blockade with Anti-PD-1 Therapy Merck Plans to Initiate Phase 2 Registrational Study with KEYTRUDA (KEYNOTE-164) to Evaluate MMR-Deficiency in Colorectal Cancer KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced results from the first study evaluating the correlation of benefit with an immunotherapy based on DNA mismatch repair (MMR) deficiency, a well-established form of genetic instability in many cancers characterized by the loss of function of the MMR pathway. Language: English Contact: MerckMedia:Pamela Eisele, 267-664-0282Claire Mulhearn, 908-200-1889orInvestors:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Notice for Annual General meeting of Dome Energy AB (publ) on June 25 2015
2015-05-29 15:21:49| Appliances - Topix.net
The shareholders of Dome Energy AB , org. nr 556533-0189, , are hereby invited for annual general meeting on Thursday June 25 at 10.00 at Park Venue on Engelbrektsgatan 9-11 in Stockholm.
RaySearch Laboratories: Resolutions at the Annual General Meeting 2015
2015-05-29 02:55:21| Appliances - Topix.net
At the Annual General Meeting of RaySearch Laboratories AB held on 28 May, 2015, the following resolutions were adopted: It was resolved that no dividends be paid out to the shareholders since the company is in a phase of rapid expansion that requires capital. The accumulated profit of SEK 75,442,000 was brought forward and balanced in the new accounts.
Tags: general
meeting
annual
laboratories
Sites : [277] [278] [279] [280] [281] [282] [283] [284] [285] [286] [287] [288] [289] [290] [291] [292] [293] [294] [295] [296] next »